Global antibiotic resistance in Streptococcus pneumoniae

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Rising antibiotic resistance in bacteria poses a significant global health threat.
• Key pathogens like Staphylococcus spp., Enterococcus spp., Pseudomonas spp., Enterobacteriaceae, Streptococcus pneumoniae, and Haemophilus influenzae exhibit increasing resistance.
• Nosocomial and community-acquired infections are increasingly challenging to treat due to antimicrobial resistance.

Purpose of the Study:

• To monitor antimicrobial susceptibility trends in community-acquired lower respiratory tract pathogens.
• To investigate the increasing resistance rates of bacteria, particularly Streptococcus pneumoniae.
• To provide data for effective treatment strategies against common respiratory pathogens.

Main Methods:

• The Alexander Project, a multinational, longitudinal surveillance program established in 1992.
• Monitoring the susceptibility of major community-acquired lower respiratory tract pathogens to various antibacterial drugs.
• Analysis of resistance patterns over time, with a focus on Streptococcus pneumoniae.

Main Results:

• A clear trend of increasing resistance of Streptococcus pneumoniae to penicillin and macrolide therapy was observed.
• Penicillin resistance in Streptococcus pneumoniae is notably high in France and Spain.
• Macrolide resistance in Streptococcus pneumoniae is a growing concern across Europe, exceeding penicillin resistance in countries like France, Spain, Belgium, and Italy.

Conclusions:

• Antimicrobial resistance, especially in Streptococcus pneumoniae, is a significant and growing public health concern.
• Specific European countries show particularly high rates of resistance, necessitating targeted surveillance and intervention.
• Continued monitoring through programs like the Alexander Project is crucial for understanding and combating antimicrobial resistance.